Clal Financial Statements From 2010 to 2025
| CBI Stock | 35.60 0.50 1.39% |
Check Clal Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clal Biotechnology's main balance sheet or income statement drivers, such as , as well as many indicators such as . Clal financial statements analysis is a perfect complement when working with Clal Biotechnology Valuation or Volatility modules.
Clal |
Clal Biotechnology Industries Company Operating Margin Analysis
Clal Biotechnology's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Clal Biotechnology Operating Margin | (0.86) % |
Most of Clal Biotechnology's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Clal Biotechnology Industries is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Clal Biotechnology Industries has an Operating Margin of -0.8593%. This is 97.55% lower than that of the Biotechnology sector and 99.23% lower than that of the Health Care industry. The operating margin for all Israel stocks is 84.4% lower than that of the firm.
Clal Biotechnology Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Clal Biotechnology's current stock value. Our valuation model uses many indicators to compare Clal Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Clal Biotechnology competition to find correlations between indicators driving Clal Biotechnology's intrinsic value. More Info.Clal Biotechnology Industries is rated fifth in return on equity category among its peers. It is rated fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Clal Biotechnology by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Clal Biotechnology's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Clal Biotechnology Financial Statements
Clal Biotechnology stakeholders use historical fundamental indicators, such as Clal Biotechnology's revenue or net income, to determine how well the company is positioned to perform in the future. Although Clal Biotechnology investors may analyze each financial statement separately, they are all interrelated. For example, changes in Clal Biotechnology's assets and liabilities are reflected in the revenues and expenses on Clal Biotechnology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Clal Biotechnology Industries. Please read more on our technical analysis and fundamental analysis pages.
Clal Biotechnology Industries Ltd. is a private equity and venture capital firm specializing in development stage, pre-clinical incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing. It operates as a subsidiary of Clal Industries and Investments Ltd. CLAL BIOTECHNOLOGY operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Clal Stock
Clal Biotechnology financial ratios help investors to determine whether Clal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Clal with respect to the benefits of owning Clal Biotechnology security.